CS logo
small CS logo
Covance Clinical Research Unit Inc.

Evansville, Indiana, United States
Pharmaceutical company in Evansville, Indiana
617 Oakley St, Evansville, IN 47710

About Covance Clinical Research Unit Inc.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Alexza Pharmaceuticals, Inc.
5
Eli Lilly and Company
4
CTI BioPharma
3
Virobay Inc.
3
ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)
2
Bristol-Myers Squibb
2
Actelion
1
Altria Client Services LLC
1
Astellas Pharma Global Development, Inc.
1
AstraZeneca
1
Celgene
1
Total Rows: 16

Clinical Trials at Covance Clinical Research Unit Inc.


During the past decade, Covance Clinical Research Unit Inc. conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 9 clinical trials were completed, i.e. on average, 81.8% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years664411000022Started TrialsCompleted Trails20152016201702468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Staccato Prochlorperazine Thorough QT/QTc
2007-10-01
2007-12-01
Completed
48
Staccato Zaleplon Single Dose Pharmacokinetics
2008-02-01
2008-03-01
Completed
40
A Study of ARQ 197 in Healthy Volunteers to Assess the Pharmacokinetic (PK) Profile in Extensive and Poor Metabolizers as Defined by Cytochrome P450 2C19 (CYP 2C19) Genotype
2008-03-01
2008-06-01
Completed
17
Bioequivalence Study of ARQ 197 Amorphous and Crystalline Polymorphs A and B in Normal Healthy Volunteers
2008-04-01
2008-06-01
Completed
24
Controlled Study of the Ability of a Smokefree Tobacco Product to Increase the Quit Rate Among Cigarette Smokers
2009-02-01
2010-06-01
Completed
250
Staccato Loxapine PK in Smokers and Nonsmokers
2009-04-01
2009-06-01
Completed
35
Staccato Loxapine Thorough QT/QTc Study
2009-04-01
2009-06-01
Completed
48
Crossover Trial of the Effect of a High-Fat Meal on the PK of Oral CHR 2797 in Healthy Male Subjects
2012-06-01
2012-09-01
Unknown status
18

Rows per page:

1–29 of 29

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Covance Clinical Research Unit Inc." #1 sponsor was "Alexza Pharmaceuticals, Inc." with 5 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "CTI BioPharma" with 3 trials sponsored, "Virobay Inc." with 3 trials sponsored and "ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 3 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Covance Clinical Research Unit Inc." #1 collaborator was "Covance" with 2 trials as a collaborator, "Chroma Therapeutics" with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "LEO Pharma" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAlexza Pharmaceuticals, Inc.: 5Alexza Pharmaceuticals, Inc.: 5Eli Lilly and Company: 4Eli Lilly and Company: 4CTI BioPharma: 3CTI BioPharma: 3Virobay Inc.: 3Virobay Inc.: 3ArQule, Inc. (a whollyowned subsidiary ofMerck Sharp andDohme, a subsidiary ofMerck & Co., Inc.): 2ArQule, Inc. (a whollyowned subsidiary ofMerck Sharp andDohme, a subsidiary ofMerck & Co., Inc.): 2Bristol-Myers Squibb: 2Bristol-Myers Squibb: 2Actelion: 1Actelion: 1Altria Client Services LLC: 1Altria Client Services LLC: 1Astellas Pharma GlobalDevelopment, Inc.: 1Astellas Pharma GlobalDevelopment, Inc.: 1AstraZeneca: 1AstraZeneca: 1

Created with Highcharts 11.1.0Top CollaboratorsCovance: 2Covance: 2Chroma Therapeutics: 1Chroma Therapeutics: 1Department of Healthand Human Services: 1Department of Healthand Human Services: 1Eli Lilly and Company: 1Eli Lilly and Company: 1LEO Pharma: 1LEO Pharma: 1Michael J. FoxFoundation forParkinson's Research: 1Michael J. FoxFoundation forParkinson's Research: 1The Parkinson Alliance: 1The Parkinson Alliance: 1

Clinical Trials Conditions at Covance Clinical Research Unit Inc.


According to Clinical.Site data, the most researched conditions in "Covance Clinical Research Unit Inc." are "Healthy" (13 trials), "Healthy Subjects" (2 trials), "Healthy Volunteers" (2 trials), "Arthritis" (1 trials) and "Cardiodynamics" (1 trials). Many other conditions were trialed in "Covance Clinical Research Unit Inc." in a lesser frequency.

Clinical Trials Intervention Types at Covance Clinical Research Unit Inc.


Most popular intervention types in "Covance Clinical Research Unit Inc." are "Drug" (26 trials), "Other" (5 trials) and "Biological" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Inhaled placebo" (3 trials), "Oral moxifloxacin" (2 trials), "Oral placebo" (2 trials) and "VBY-036" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Covance Clinical Research Unit Inc.


The vast majority of trials in "Covance Clinical Research Unit Inc." are 24 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Clinical Trials Status at Covance Clinical Research Unit Inc.


Currently, there are NaN active trials in "Covance Clinical Research Unit Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Covance Clinical Research Unit Inc., undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Covance Clinical Research Unit Inc., 25 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 1: 25Phase 1: 25Phase 4: 2Phase 4: 2Not Applicable: 1Not Applicable: 1Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 27Completed: 27Terminated: 1Terminated: 1Unknown status: 1Unknown status: 1